98
|
275
|
8pboA |
Deep interactome learning for generative drug design |
100
|
276
|
8fkdA |
Crystal structure of ppargamma ligand-binding domain in complex with n-cor peptide and inverse agonist sr33068 |
4
|
14
|
8fkeD |
Crystal structure of ppargamma ligand-binding domain in complex with n-cor peptide and inverse agonist sr32904 |
103
|
276
|
8fkcA |
Crystal structure of ppargamma ligand-binding domain in complex with n-cor peptide and inverse agonist sr33544 |
103
|
276
|
8fkeA |
Crystal structure of ppargamma ligand-binding domain in complex with n-cor peptide and inverse agonist sr32904 |
4
|
14
|
8fkdD |
Crystal structure of ppargamma ligand-binding domain in complex with n-cor peptide and inverse agonist sr33068 |
4
|
13
|
8fkcD |
Crystal structure of ppargamma ligand-binding domain in complex with n-cor peptide and inverse agonist sr33544 |
5
|
14
|
8fkfD |
Crystal structure of ppargamma ligand-binding domain in complex with n-cor peptide and inverse agonist sr36706 |
104
|
276
|
8fkfA |
Crystal structure of ppargamma ligand-binding domain in complex with n-cor peptide and inverse agonist sr36706 |
98
|
270
|
8fhfA |
Crystal structure of ppargamma ligand-binding domain in complex with zinc5672437 |
100
|
275
|
8fhgB |
Crystal structure of ppargamma ligand-binding domain in complex with n-cor peptide and zinc5672437 |
4
|
11
|
8fheD |
Crystal structure of ppargamma ligand-binding domain in complex with n-cor peptide and gw9662 |
4
|
11
|
8fhgD |
Crystal structure of ppargamma ligand-binding domain in complex with n-cor peptide and zinc5672437 |
102
|
275
|
8fheB |
Crystal structure of ppargamma ligand-binding domain in complex with n-cor peptide and gw9662 |
103
|
272
|
6ms7A |
Peroxisome proliferator-activated receptor gamma ligand binding domain in complex with a novel selective ppar-gamma modulator vsp-77 |
1
|
11
|
6ms7B |
Peroxisome proliferator-activated receptor gamma ligand binding domain in complex with a novel selective ppar-gamma modulator vsp-77 |
90
|
268
|
7e2oA |
X-ray crystal structure of ppargamma r288h mutant. |
95
|
269
|
8wfeA |
The crystal structure of pparg from biortus. |
98
|
271
|
8hhpA |
Crystal structure of pparg-lbd complexed with three partial agonists, one ntzdpa and two lt175 |
100
|
269
|
7woxA |
Ppargamma antagonist (mmt-160)- ppargamma lbd complex |
99
|
272
|
7qb1AAA |
Pparg in complex with inhibitor |
102
|
275
|
7p4eA |
Crystal structure of ppargamma in complex with compound fl217 |
93
|
269
|
8hhqA |
Covalent bond formation between cysteine of pparg-lbd and iodoacetic acid |
100
|
277
|
8cphA |
Crystal structure of ppar gamma (pparg) in complex with wy-14643 (inactive form) |
109
|
277
|
8atyA |
Crystal structure of ppar gamma (pparg) in complex with jp85 (compound 1). |
109
|
276
|
8atzA |
Crystal structure of ppar gamma (pparg) in complex with sa112 (compound 2). |
104
|
277
|
8cpiA |
Crystal structure of ppar gamma (pparg) in complex with wy-14643 |
95
|
275
|
8cpjA |
Crystal structure of ppar gamma (pparg) in an inactive form |
97
|
270
|
8dk4A |
Peroxisome proliferator-activated receptor gamma in complex with vsp-51-2 |
2
|
11
|
8dk4B |
Peroxisome proliferator-activated receptor gamma in complex with vsp-51-2 |
3
|
15
|
7sqaC |
Ppar gamma lbd bound to sr10221 and smrt corepressor motif |
89
|
262
|
7sqaA |
Ppar gamma lbd bound to sr10221 and smrt corepressor motif |
89
|
277
|
7sqbA |
Ppar gamma lbd bound to inverse agonist sr10221 |
98
|
274
|
8c0cA |
X-ray crystal structure of ppar gamma ligand binding domain in complex with cz46 |
95
|
274
|
8adfA |
X-ray crystal structure of ppar gamma ligand binding domain in complex with cz39 |
100
|
270
|
8bf1A |
High-resolution structure of unliganded ppar gamma in complex with the peptide pgc-1 alpha |
2
|
11
|
8bf1B |
High-resolution structure of unliganded ppar gamma in complex with the peptide pgc-1 alpha |
96
|
271
|
8bf2A |
Human ppargamma in complex with mehp bound to the af-2 and omega sub-pockets |
87
|
270
|
8bffA |
Human ppargamma in complex with minch bound to the af-2 sub-pocket |
97
|
270
|
8b95A |
Crystal structure of pparg and ncor2 with bay-9683, an inverse agonist |
3
|
11
|
8b95C |
Crystal structure of pparg and ncor2 with bay-9683, an inverse agonist |
3
|
12
|
8b93C |
Crystal structure of pparg and ncor2 with an inverse agonist (compound 15b) |
3
|
11
|
8b91C |
Crystal structure of mutant pparg (c313a) and ncor2 with an inverse agonist (compound si-1) |
3
|
11
|
8b94C |
Crystal structure of pparg and ncor2 with bay-5516, an inverse agonist |
99
|
271
|
8b90A |
Crystal structure of pparg and ncor2 with an inverse agonist (compound 7d) |
4
|
13
|
8b92C |
Crystal structure of pparg and ncor2 with an inverse agonist (compound si-2) |
102
|
271
|
8b91A |
Crystal structure of mutant pparg (c313a) and ncor2 with an inverse agonist (compound si-1) |
3
|
12
|
8b8xC |
Crystal structure of pparg and ncor2 with sr10221, an inverse agonist |
4
|
11
|
8b8yC |
Crystal structure of pparg and ncor2 with an inverse agonist (compound 7e) |
101
|
273
|
8b8xA |
Crystal structure of pparg and ncor2 with sr10221, an inverse agonist |